Chitosan Nanoparticles-Based Cancer Drug Delivery: Application and Challenges
Marine Drugs · 28.03.2023 · 21 (4) · 211
DOI: 10.3390/md21040211 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Marine Drugs, online erschienen am 28.03.2023. Verfasst von Bhuvi Sachdeva und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics and Astrophysics, Bhagini Nivedita College, University of Delhi, Delhi 110072, India. Hauptthemen laut MEDLINE: Chitosan, Nanoparticles, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 145-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chitin is the second most abundant biopolymer consisting of N-acetylglucosamine units and is primarily derived from the shells of marine crustaceans and the cell walls of organisms (such as bacteria, fungi, and algae). Being a biopolymer, its materialistic properties, such as biodegradability, and biocompatibility, make it a suitable choice for biomedical applications. Similarly, its deacetylated derivative, chitosan, exhibits similar biocompatibility and biodegradability properties, making it a suitable support material for biomedical applications. Furthermore, it has intrinsic material properties such as antioxidant, antibacterial, and antitumor. Population studies have projected nearly 12 million cancer patients across the globe, where most will be suffering from solid tumors. One of the shortcomings of potent anticancer drugs is finding a suitable cellular delivery material or system. Therefore, identifying new drug carriers to achieve effective anticancer therapy is becoming essential. This paper focuses on the strategies implemented using chitin and chitosan biopolymers in drug delivery for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physics and Astrophysics, Bhagini Nivedita College, University of Delhi, Delhi 110072, India.
- GloNeuro, Sector 107, Vishwakarma Road, Noida 201301, India.
- Department of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, 00076 Espoo, Finland.
- ICMR-National Institute of Nutrition, Tarnaka, Hyderabad 500007, India.
- School of Chemical Engineering, Yeungnam University, Gyeonsang 38541, Republic of Korea.
- Research Institute of Cell Culture, Yeungnam University, 280 Daehak-Ro, Gyeongsan 38541, Republic of Korea.
ORCID-Profile: Punya Sachdeva, Arvind Negi, Shampa Ghosh, Sungsoo Han, Saikat Dewanjee, Rakesh Bhaskar, Jitendra Kumar Sinha, Ana Cláudia Paiva-Santos, Niraj Kumar Jha, Kavindra Kumar Kesari
Zitieren
APA
Sachdeva, B., Sachdeva, P., Negi, A., Ghosh, S., Han, S., Dewanjee, S., Jha, S. K., Bhaskar, R., Sinha, J. K., Paiva-Santos, A. C., Jha, N. K., & Kesari, K. K. (2023). Chitosan Nanoparticles-Based Cancer Drug Delivery: Application and Challenges. Marine Drugs, 21(4), 211. https://doi.org/10.3390/md21040211
Vancouver
Sachdeva B, Sachdeva P, Negi A, Ghosh S, Han S, Dewanjee S, et al. Chitosan Nanoparticles-Based Cancer Drug Delivery: Application and Challenges. Marine Drugs. 2023;21(4):211. doi:10.3390/md21040211
BibTeX
@article{Sachdeva2023,
author = {Sachdeva, Bhuvi and Sachdeva, Punya and Negi, Arvind and Ghosh, Shampa and Han, Sungsoo and Dewanjee, Saikat and Jha, Saurabh Kumar and Bhaskar, Rakesh and Sinha, Jitendra Kumar and Paiva-Santos, Ana Cláudia and Jha, Niraj Kumar and Kesari, Kavindra Kumar},
title = {Chitosan Nanoparticles-Based Cancer Drug Delivery: Application and Challenges},
journal = {Marine Drugs},
year = {2023},
volume = {21},
number = {4},
pages = {211},
doi = {10.3390/md21040211}
}
EUVIMED